FDA TELLS TRIPATH THAT NEW DATA IS NEEDED FOR DEVICE APPROVAL

TriPath Imaging said it has withdrawn a regulatory approval from the FDA after the agency told the company it needed different data in order to move ahead with approvals for TriPath's FocalPoint GS Imaging System. The system is used to help pathologists evaluate slides obtained in medical tests.

The Business Journal of the Greater Triad Area (http://triad.bizjournals.com/triad/stories/2005/09/26/daily16.html?jst=b_ln_hl)